Class information for:
Level 2: ALPHA1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//EMPHYSEMA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1704 6129 41.7 74%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
25 108416 RESPIRATORY SYSTEM//CYSTIC FIBROSIS//CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Classes in level below (level 1)


ID, lev. below Publications Label for level below
1131 2736 ALPHA1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//ANTITRYPSIN
2509 2151 CIGARETTE SMOKE//EMPHYSEMA//LUNG BIOL DIS PROGRAM
14026 733 OXIDATIVE DAMAGE OF PROTEINS//DIPARTIMENTO AREA SERV DIAGNOST//BREATH PENTANE
17989 509 COPD RELATED PHENOTYPES//IREB2//FAM13A

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ALPHA1 ANTITRYPSIN DEFICIENCY Author keyword 298 67% 4% 268
2 ALPHA 1 ANTITRYPSIN Author keyword 220 44% 6% 381
3 EMPHYSEMA Author keyword 82 20% 6% 370
4 CIGARETTE SMOKE Author keyword 81 23% 5% 310
5 ANTITRYPSIN Author keyword 32 62% 1% 33
6 SERPIN Author keyword 30 20% 2% 136
7 LUNG INVEST UNIT Address 24 57% 0% 29
8 AUGMENTATION THERAPY Author keyword 22 50% 1% 32
9 SERPINS Author keyword 22 29% 1% 65
10 PI SUBTYPES Author keyword 21 85% 0% 11

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ALPHA1 ANTITRYPSIN DEFICIENCY 298 67% 4% 268 Search ALPHA1+ANTITRYPSIN+DEFICIENCY Search ALPHA1+ANTITRYPSIN+DEFICIENCY
2 ALPHA 1 ANTITRYPSIN 220 44% 6% 381 Search ALPHA+1+ANTITRYPSIN Search ALPHA+1+ANTITRYPSIN
3 EMPHYSEMA 82 20% 6% 370 Search EMPHYSEMA Search EMPHYSEMA
4 CIGARETTE SMOKE 81 23% 5% 310 Search CIGARETTE+SMOKE Search CIGARETTE+SMOKE
5 ANTITRYPSIN 32 62% 1% 33 Search ANTITRYPSIN Search ANTITRYPSIN
6 SERPIN 30 20% 2% 136 Search SERPIN Search SERPIN
7 AUGMENTATION THERAPY 22 50% 1% 32 Search AUGMENTATION+THERAPY Search AUGMENTATION+THERAPY
8 SERPINS 22 29% 1% 65 Search SERPINS Search SERPINS
9 PI SUBTYPES 21 85% 0% 11 Search PI+SUBTYPES Search PI+SUBTYPES
10 LOOP SHEET POLYMERIZATION 20 100% 0% 9 Search LOOP+SHEET+POLYMERIZATION Search LOOP+SHEET+POLYMERIZATION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ALPHA1 ANTITRYPSIN DEFICIENCY 659 57% 13% 785
2 ALPHA 1 ANTITRYPSIN 177 34% 7% 426
3 REACTIVE LOOP 131 88% 1% 61
4 ANTITRYPSIN DEFICIENCY 122 86% 1% 62
5 SMOKE INDUCED EMPHYSEMA 118 55% 2% 149
6 EMPHYSEMA 107 18% 9% 546
7 INDUCED EMPHYSEMA 103 52% 2% 140
8 SEVERE ALPHA1 ANTITRYPSIN DEFICIENCY 99 88% 1% 46
9 ALPHA 1 PROTEINASE INHIBITOR 98 30% 5% 280
10 AUGMENTATION THERAPY 87 65% 1% 83

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 13% 1% 65

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Current status of gene therapy for alpha-1 antitrypsin deficiency 2015 2 57 54%
Suspecting and Testing for Alpha-1 Antitrypsin Deficiency-An Allergist's and/or Immunologist's Perspective 2015 1 26 96%
A Review of alpha(1)-Antitrypsin Deficiency 2012 61 143 84%
MECHANISMS OF DISEASE Immunologic Aspects of Chronic Obstructive Pulmonary Disease 2009 250 78 50%
Recent advances in pre-clinical mouse models of COPD 2014 17 102 55%
Pathogenesis of chronic obstructive pulmonary disease 2012 72 92 55%
Acute-phase protein alpha 1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats 2015 1 119 64%
Immunology of asthma and chronic obstructive pulmonary disease 2008 403 104 29%
alpha 1-antitrypsin deficiency 2005 223 91 85%
Cytokine inhibition in the treatment of COPD 2014 17 200 46%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LUNG INVEST UNIT 24 57% 0.5% 29
2 LUNG BIOL DIS PROGRAM 11 24% 0.6% 39
3 AIRWAYS DIS SECT 10 30% 0.5% 28
4 AIRWAY DIS SECT 10 25% 0.6% 34
5 EVALUAT RISKS HUMAN REPROD 9 83% 0.1% 5
6 AD T PROJECT 8 75% 0.1% 6
7 PROT STRAIN 8 100% 0.1% 5
8 NIHR TRANSLAT IL 7 56% 0.1% 9
9 COPD GRP 7 67% 0.1% 6
10 LUNG FUNCT SLEEP 6 50% 0.1% 9

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000042000 ELAFIN//SLPI//SECRETORY LEUKOCYTE PROTEASE INHIBITOR
2 0.0000020122 COPD//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//PULMONARY REHABILITATION
3 0.0000012006 INTERRUPTER TECHNIQUE//FORCED OSCILLATION TECHNIQUE//SPIROMETRY
4 0.0000010399 EXHALED BREATH CONDENSATE//EXHALED NITRIC OXIDE//JOURNAL OF BREATH RESEARCH
5 0.0000010039 MASPIN//RARRES3//TIG3
6 0.0000009139 ENVIRONMENTAL CIGARETTE SMOKE//STRAIN A J MICE//LUNG TUMORS
7 0.0000007372 UROKINASE RECEPTOR//FIBRINOLYSIS//PAI 1
8 0.0000006823 BRONCHIECTASIS//PRIMARY CILIARY DYSKINESIA//MUCOCILIARY CLEARANCE
9 0.0000006537 NON NEURONAL ACETYLCHOLINE//CHOLINERGIC ANTI INFLAMMATORY PATHWAY//HEMICHOLINIUM 3
10 0.0000006471 ASTHMA//AIRWAY SMOOTH MUSCLE//EOSINOPHILS